Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

Eugenio Fiorentino, Antonio Russo, Giuseppe Cicero, Sergio Rizzo, Giuseppe Bronte, Marta Castiglia, Francesco Passiglia, Rolfo, C; Giovannetti, E; Pauwels, P; Vullo, Fl; Van Meerbeeck, J

Risultato della ricerca: Articlepeer review

48 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.'. Insieme formano una fingerprint unica.

Medicine & Life Sciences